EP3074026A4 - Composition, système, et méthode pour le traitement de la peau - Google Patents

Composition, système, et méthode pour le traitement de la peau Download PDF

Info

Publication number
EP3074026A4
EP3074026A4 EP14863961.0A EP14863961A EP3074026A4 EP 3074026 A4 EP3074026 A4 EP 3074026A4 EP 14863961 A EP14863961 A EP 14863961A EP 3074026 A4 EP3074026 A4 EP 3074026A4
Authority
EP
European Patent Office
Prior art keywords
composition
treating skin
skin
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP14863961.0A
Other languages
German (de)
English (en)
Other versions
EP3074026A1 (fr
EP3074026B1 (fr
Inventor
Alan Lorne Perlmutter
JR. Donald H. LEAMAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dtr Dermal Therapy Research Inc
BIOMEDICAL CONCEPTS LLC
Original Assignee
D T R DERMAL THERAPY RES Inc
DTR Dermal Therapy Research Inc
BIOMEDICAL CONCEPTS LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D T R DERMAL THERAPY RES Inc, DTR Dermal Therapy Research Inc, BIOMEDICAL CONCEPTS LLC filed Critical D T R DERMAL THERAPY RES Inc
Priority to EP20150599.7A priority Critical patent/EP3656388A1/fr
Publication of EP3074026A1 publication Critical patent/EP3074026A1/fr
Publication of EP3074026A4 publication Critical patent/EP3074026A4/fr
Application granted granted Critical
Publication of EP3074026B1 publication Critical patent/EP3074026B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A61K8/988—Honey; Royal jelly, Propolis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
EP14863961.0A 2013-11-25 2014-11-25 Composition, système, et méthode pour le traitement de la peau Active EP3074026B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP20150599.7A EP3656388A1 (fr) 2013-11-25 2014-11-25 Composition, système et procédé de traitement de la peau

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361908611P 2013-11-25 2013-11-25
PCT/CA2014/051124 WO2015074159A1 (fr) 2013-11-25 2014-11-25 Composition, système, et méthode pour le traitement de la peau

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP20150599.7A Division EP3656388A1 (fr) 2013-11-25 2014-11-25 Composition, système et procédé de traitement de la peau

Publications (3)

Publication Number Publication Date
EP3074026A1 EP3074026A1 (fr) 2016-10-05
EP3074026A4 true EP3074026A4 (fr) 2017-05-31
EP3074026B1 EP3074026B1 (fr) 2020-01-08

Family

ID=53178763

Family Applications (2)

Application Number Title Priority Date Filing Date
EP20150599.7A Pending EP3656388A1 (fr) 2013-11-25 2014-11-25 Composition, système et procédé de traitement de la peau
EP14863961.0A Active EP3074026B1 (fr) 2013-11-25 2014-11-25 Composition, système, et méthode pour le traitement de la peau

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP20150599.7A Pending EP3656388A1 (fr) 2013-11-25 2014-11-25 Composition, système et procédé de traitement de la peau

Country Status (5)

Country Link
US (2) US20170087194A1 (fr)
EP (2) EP3656388A1 (fr)
AU (2) AU2014353853A1 (fr)
CA (1) CA2931564C (fr)
WO (1) WO2015074159A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2535666B (en) 2014-04-30 2017-03-29 Matoke Holdings Ltd Antimicrobial compositions
WO2018026825A1 (fr) * 2016-08-01 2018-02-08 Parvizi Surgical Innovation, Llc Composition anti-microbienne et leurs méthodes d'utilisation
AU2017380471B2 (en) * 2016-12-23 2023-12-21 Mm Health Ltd Topical formulation comprising green lipped mussel and honey
GB201712501D0 (en) * 2017-08-03 2017-09-20 Neem Biotech Ltd An antimicrobial composition
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
JP2019214520A (ja) * 2018-06-12 2019-12-19 花王株式会社 角層剥離改善剤
WO2023195538A1 (fr) * 2022-04-08 2023-10-12 ハニデュー株式会社 Poudre de sirop de patate formée à partir de poudre ou de granulés de sirop de patate douce, surnageant de celle-ci, ou les deux

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1677811B1 (fr) * 2003-10-17 2008-09-10 Camelyn Ltd Medicament a base de miel, sa preparation et son utilisation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
US5804165A (en) * 1996-07-24 1998-09-08 Arnold; Michael J. Antiplaque oral composition
ATE400242T1 (de) * 1997-11-07 2008-07-15 Medion Res Lab Inc Visköse zusammensetzungen mit kohlendioxid
NZ505514A (en) 2000-06-30 2003-02-28 Bee & Herbal New Zealand Ltd Method of manufacturing a wound dressing for the application of honey
US6548556B2 (en) 2000-12-27 2003-04-15 Healthpoint, Ltd. Stable enzymatic wound debrider
SE522529C2 (sv) * 2001-04-12 2004-02-17 Medicarb Ab Effervescent fastämneskomposition innefattande som aktiv komponent kitosan, dess derivat och salter därav, användning samt framställning därav
US20040147534A1 (en) * 2003-01-23 2004-07-29 Foote Mary Ann Topical composition and method for treating occlusive wounds
CN1750836A (zh) 2003-03-04 2006-03-22 日商·新化学人股份有限公司 二氧化碳经皮肤经粘膜的吸收方法及美容方法和治疗方法
US20040258765A1 (en) * 2003-06-23 2004-12-23 Gee Gilbert C. Method for treatment of sores and lesions of the skin
AU2005261276A1 (en) 2004-07-13 2006-01-19 Mediwound Ltd. Compositions and methods for dermatological wound healing
CN101209344B (zh) * 2006-12-28 2012-07-04 赵超英 高渗液组合物在制备促进伤口愈合的药物中的应用
JP2010095454A (ja) * 2008-10-14 2010-04-30 Cyclochem:Kk 抗菌組成物
US20110104279A1 (en) * 2009-11-04 2011-05-05 Marraccini Philip A Healing powder and method of use thereof
MX2012006661A (es) * 2009-12-08 2012-11-12 Healthpoint Ltd Composiciones enzimaticas de desbridamiento de heridas con actividad enzimatica mejorada.
KR20120125465A (ko) * 2010-01-08 2012-11-15 프로피브릭스 비.브이. 건조 분말 피브린 실란트
CA2791626A1 (fr) 2011-10-04 2013-04-04 Biomedical Concepts Llc Methode pour traitement de debridement prealable des tissus cutanes non viables et compositions et systemes connexes
CN103357062B (zh) * 2012-03-26 2015-10-28 约泰实业股份有限公司 纤维水凝胶及其制备方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1677811B1 (fr) * 2003-10-17 2008-09-10 Camelyn Ltd Medicament a base de miel, sa preparation et son utilisation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
RUSSELL K M ET AL: "Identification of Some Antibacterial Constituents of New Zealand Manuka Honey", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, AMERICAN CHEMICAL SOCIETY, BOOKS AND JOURNALS DIVISION, vol. 38, no. 1, 1 January 1990 (1990-01-01), pages 10 - 13, XP008149222, ISSN: 0021-8561, DOI: 10.1021/JF00091A002 *
SASIKALA L ET AL: "Manuka honey loaded chitosan hydrogel films for wound dressing applications", INTERNATIONAL JOURNAL OF PHARMTECH RESEARCH 2013 SPHINX KNOWLEDGE HOUSE IND, vol. 5, no. 4, October 2013 (2013-10-01), pages 1774 - 1785, XP055366819, ISSN: 0974-4304 *
See also references of WO2015074159A1 *
STEPHENS J M ET AL: "Phenolic compounds and methylglyoxal in some New Zealand manuka and kanuka honeys", FOOD CHEMISTRY, ELSEVIER LTD, NL, vol. 120, no. 1, 1 May 2010 (2010-05-01), pages 78 - 86, XP026799324, ISSN: 0308-8146, [retrieved on 20090926] *

Also Published As

Publication number Publication date
EP3656388A1 (fr) 2020-05-27
AU2020201781B2 (en) 2022-01-27
AU2014353853A1 (en) 2016-07-07
US20170087194A1 (en) 2017-03-30
CA2931564C (fr) 2022-08-30
NZ759509A (en) 2021-11-26
WO2015074159A1 (fr) 2015-05-28
EP3074026A1 (fr) 2016-10-05
NZ721272A (en) 2021-11-26
EP3074026B1 (fr) 2020-01-08
CA2931564A1 (fr) 2015-05-28
AU2020201781A1 (en) 2020-03-26
US20220288134A1 (en) 2022-09-15

Similar Documents

Publication Publication Date Title
HK1215378A1 (zh) 藥物組合物、治療方法及其用途
EP3265053A4 (fr) Procédés de traitement de la peau
EP3000088A4 (fr) Procédé et système pour maintenir ou améliorer le bien-être
EP3090525A4 (fr) Système et procédé pour standards de protocoles biométriques
EP3050527A4 (fr) Outil de traitement et système de traitement
EP3036675A4 (fr) Système et procédé de gestion d'identité
EP3071279A4 (fr) Dispositif, système et méthode permettant de réduire les céphalées
EP3025672A4 (fr) Système médical et procédé de commande pour celui-ci
EP2967633A4 (fr) Dispositifs, systèmes et procédés pour le traitement de la peau
EP3038635A4 (fr) Systèmes, compositions et procédés de transplantation et de traitement d'états pathologiques
EP3030186A4 (fr) Procédé et appareil pour le traitement du mélasme dermique
EP3009897A4 (fr) Dispositif de distribution, système de distribution et procédé de distribution
EP3193862A4 (fr) Composition cannabinoïde et méthode de traitement de la douleur
EP3028189A4 (fr) Procédé et système de fourniture de termes recommandés
EP3025671A4 (fr) Système médical et procédé de commande pour celui-ci
EP3037053A4 (fr) Outil et système de traitement
EP3078317A4 (fr) Procédé de commande d'endoscope et système d'endoscope
EP3074026A4 (fr) Composition, système, et méthode pour le traitement de la peau
EP2998948A4 (fr) Système de chiffrement, procédé de chiffrement et programme de chiffrement
EP3018100A4 (fr) Système et procédé de traitement d'eau
EP3034023A4 (fr) Instrument de traitement, et système de traitement
EP3015053A4 (fr) Système d'endoscope et procédé de fonctionnement de système d'endoscope
EP3079768A4 (fr) Procédé et système pour le traitement acoustique de matière
EP3006952A4 (fr) Système de positionnement, procédé de positionnement et programme de positionnement
EP3352729A4 (fr) Méthodes et compositions de traitement de la peau

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160623

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BIOMEDICAL CONCEPTS LLC

Owner name: D.T.R. DERMAL THERAPY RESEARCH INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20170504

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20180208

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602014059875

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61K0035640000

Ipc: A61Q0019000000

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 33/00 20060101ALI20190618BHEP

Ipc: A61K 35/644 20150101ALI20190618BHEP

Ipc: A61K 38/48 20060101ALI20190618BHEP

Ipc: A61K 36/61 20060101ALI20190618BHEP

Ipc: A61P 17/02 20060101ALI20190618BHEP

Ipc: A61K 36/185 20060101ALI20190618BHEP

Ipc: A61K 31/375 20060101ALI20190618BHEP

Ipc: A61K 31/723 20060101ALI20190618BHEP

Ipc: A61K 35/64 20150101AFI20190618BHEP

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/12 20060101ALI20190703BHEP

Ipc: A61Q 19/00 20060101AFI20190703BHEP

Ipc: A61K 35/644 20150101ALI20190703BHEP

Ipc: A61Q 19/10 20060101ALI20190703BHEP

Ipc: A61K 9/00 20060101ALI20190703BHEP

Ipc: A61L 15/40 20060101ALI20190703BHEP

Ipc: A61K 8/98 20060101ALI20190703BHEP

Ipc: A61K 36/61 20060101ALI20190703BHEP

Ipc: A61K 8/19 20060101ALI20190703BHEP

Ipc: A61L 15/18 20060101ALI20190703BHEP

Ipc: A61K 38/48 20060101ALI20190703BHEP

Ipc: A61K 36/185 20060101ALI20190703BHEP

Ipc: A61K 47/02 20060101ALI20190703BHEP

Ipc: A61K 33/10 20060101ALI20190703BHEP

Ipc: A61K 31/375 20060101ALI20190703BHEP

Ipc: A61K 9/06 20060101ALI20190703BHEP

INTG Intention to grant announced

Effective date: 20190718

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602014059875

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1221961

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200215

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602014059875

Country of ref document: DE

Owner name: D.T.R. DERMAL THERAPY RESEARCH INC., LONDON, CA

Free format text: FORMER OWNERS: BIOMEDICAL CONCEPTS LLC, NEW RIVER, AZ, US; D.T.R. DERMAL THERAPY RESEARCH INC., LONDON, ONTARIO, CA

Ref country code: DE

Ref legal event code: R081

Ref document number: 602014059875

Country of ref document: DE

Owner name: BIOMEDICAL CONCEPTS LLC, GILBERT, US

Free format text: FORMER OWNERS: BIOMEDICAL CONCEPTS LLC, NEW RIVER, AZ, US; D.T.R. DERMAL THERAPY RESEARCH INC., LONDON, ONTARIO, CA

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: STOLMAR AND PARTNER INTELLECTUAL PROPERTY S.A., CH

Ref country code: NL

Ref legal event code: FP

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: D.T.R. DERMAL THERAPY RESEARCH INC.

Owner name: BIOMEDICAL CONCEPTS LLC

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200531

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200408

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200508

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200408

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200409

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602014059875

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1221961

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200108

26N No opposition filed

Effective date: 20201009

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201125

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200108

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20231020

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231019

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20231020

Year of fee payment: 10

Ref country code: IE

Payment date: 20231023

Year of fee payment: 10

Ref country code: FR

Payment date: 20231020

Year of fee payment: 10

Ref country code: DE

Payment date: 20231019

Year of fee payment: 10

Ref country code: CH

Payment date: 20231201

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20231019

Year of fee payment: 10